Thank you for supporting beNeFit XII! We continue to be humbled by the support shown by the community for the last 12 years in joining us to find a cure for NF. Remarkable progress has been made in large part because of investments made by event participants and sponsors like you for more than a decade. Take a look at our scientific research update video HERE to see the work you have helped fund.

On November 23rd, 2024, 1,800 supporters showed up for a moody masquerade and their commitment to cure NF was felt throughout Huntington Place. For the third consecutive year, we raised nearly $9 million in support of research and advocacy for NF Forward and the Children's Tumor Foundation. Thanks to you, we are even closer to living in a world without NF. We have seen great advancements, including groundbreaking treatments and therapies that are positively impacting the lives of those living with NF. This progress continues to be possible because of your generosity.

For the second year the Head and Heart award was presented to a distinguished individual whose life’s work is dedicated to finding advancements in treatment for NF. It was an honor to bestow this year’s award to Dr. Nancy Ratner, whose work and impact is captured HERE in this video.

Every year we have the privilege of celebrating someone whose life has been impacted by NF and sharing their story any we’ve heard. Devin has never let NF keep him from pursuing his dreams and he’s made it a goal to inspire others along the way.

Strength & Honor

Devin Allen

Devin Allen was born and raised in Detroit, where he proudly calls himself a Detroit native. As the oldest of three siblings, he faced some challenges early on. At 3 years old, he was diagnosed with scoliosis and later found out that he has neurofibromatosis. He has undergone 15 surgeries but nothing has stopped him from achieving his dreams. He is currently pursuing his passion as a tech geek in his work and is thankful for his incredible support system. He lives his life to the fullest and hopes to inspire others with his journey of resilience.

Head & Heart

Dr. Nancy Ratner

Dr. Ratner is currently a Professor in the Department of Pediatrics at Cincinnati Children's Hospital and holds the Endowed Chair in Cancer Biology. She uses sophisticated methods of gene expression and develops animal and cell culture models to study neurofibroma formation. She was instrumental to the identification of MEK inhibitors as neurofibroma therapeutics, which was approved by the FDA in 2022. She has received numerous awards, authored over 150 peer-reviewed manuscripts, and has served on numerous national and international NF review panels.

Honorary Committee